The Future of Clinical Research in Europe: The Value of a Comprehensive Sample Management Strategy

This symposium is being led by four industry experts who will provide

an update on the future of clinical trials in Europe. It will focus on the

importance of establishing a comprehensive sample management

strategy to support the development of pharmacogenomics research,

novel biomarkers, new drug therapies and companion diagnostics.

The speakers will highlight emerging models and processes for the

optimization of sample assets to support future drug development,

approvals and expanded use enabling companies to maximize research

efforts, minimize risk and generate value.

This in-depth symposium will feature an expert panel and will discuss:

·         The Future of Clinical Trials in Europe: Upcoming Revisions to the EU Clinical Trials Directive - Alexander Roussanov, Associate, Hogan Lovells International LLP, Brussels

·         Comprehensive Sample Management in Translational Research: How to Develop Strategies and Metric Tracking to Advance Personalized Medicine - Hyung Park, Director Translational Development Operations, Celgene

·         Prospective and Retrospective Sample Management:  How to Manage Sites and Leverage Sample Assets to Support Clinical Research - Agnes Rivaille, Scientific Affairs Director-Europe, PRA International

·         Virtual Sample Management: How to Leverage Technology to Improve Sample Asset Utilization and Research Results - Steve Sweeney, Head of Clinical Technologies, Infinity Pharmaceuticals, Inc.